Cite
The molecular mechanism of a novel derivative of BTO-956 induced apoptosis in human myelomonocytic lymphoma cells.
MLA
Li, Yu-Lin, et al. “The Molecular Mechanism of a Novel Derivative of BTO-956 Induced Apoptosis in Human Myelomonocytic Lymphoma Cells.” Apoptosis : An International Journal on Programmed Cell Death, vol. 26, no. 3–4, Apr. 2021, pp. 219–31. EBSCOhost, https://doi.org/10.1007/s10495-021-01664-2.
APA
Li, Y.-L., Zhou, D.-J., Cui, Z.-G., Sun, L., Feng, Q.-W., Zakki, S. A., Hiraku, Y., Wu, C.-A., & Inadera, H. (2021). The molecular mechanism of a novel derivative of BTO-956 induced apoptosis in human myelomonocytic lymphoma cells. Apoptosis : An International Journal on Programmed Cell Death, 26(3–4), 219–231. https://doi.org/10.1007/s10495-021-01664-2
Chicago
Li, Yu-Lin, De-Jun Zhou, Zheng-Guo Cui, Lu Sun, Qian-Wen Feng, Shahbaz Ahmad Zakki, Yusuke Hiraku, Cheng-Ai Wu, and Hidekuni Inadera. 2021. “The Molecular Mechanism of a Novel Derivative of BTO-956 Induced Apoptosis in Human Myelomonocytic Lymphoma Cells.” Apoptosis : An International Journal on Programmed Cell Death 26 (3–4): 219–31. doi:10.1007/s10495-021-01664-2.